Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis

NCT01382654 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: epinastine 0.1%
DRUG: epinastine 0.1% with taste masking agent
DRUG: epinastine 0.2%
DRUG: epinastine 0.2% with taste masking agent
DRUG: azelastine 0.1%

Sponsor

Merck Sharp & Dohme LLC